DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20151333

A study of adverse vaccine events among pediatric age group in a tertiary medical college hospital

Gramle Amol, Asmita Narayan, R. Shubha

Abstract


Background: Vaccines are pivotal health products that are used and administered
prophylactically to a large number of healthy individuals. A significant proportion of
vaccines are administered to the pediatric age group, particularly to the neonates and
infants as part of the national immunization programmes. As with any drug, untoward
reaction can occur with the administration of vaccines. Most of the clinical trials with
the vaccines are conducted and validated in a relatively small sample size. Active
monitoring as part of the Pharmacovigilance programme is imperative to identify
rare or deferred adverse vaccine events (AVE).

Methods: A prospective, single center, observational, naturalistic study on report
forms in pediatric age group, who may develop AVE in Sapthagiri Institute of
Medical Sciences and Research Center, Bengaluru, was conducted during the study
time widow, from February 20, 2014, to April 20th, 2014. Children under 5 years of
age were included in the study. All children more than 5 years of age were excluded
from the study. The causality assessment were attempted to be recorded as per the
Naranjo score, which is used to quantitatively evaluate the association between AVE
and vaccines.

Results: 19.04% of children aged 1-5 years of age documented with adverse event
following immunization (AEFI) (p=0.036). It was found that either a naïve or the
fully immunized children suffered from the AEFI most of which was trivial. Fever
was the most common AEFI reported followed by an excess cry. The incidence of
fever reported was substantially high following the DPT vaccine.
Conclusions: All the AEFI received through the telephonic calls were documented.
There was no mortality or a major adverse event reported. Maximum AEFI were
documented in the neonates and the children 1-5 years of age which was statistically
significant. In addition, the study provides a scope for further research with reference
to the inter-age group variability. The immune mechanism behind such a difference
also needs to be explored.


Keywords


Vaccines, Adverse vaccine events, Neonates

Full Text:

PDF

References


Goldman GS, Miller NZ. Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010. Hum Exp Toxicol. 2012;31(10):1012-21.

Aagaard L, Hansen EW, Hansen EH. Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade. Eur J Clin Pharmacol. 2011;67(3):283-8.

Chen RT, Hibbs B. Vaccine safety: current and future challenges. Pediatr Ann. 1998;27(7):445-55.

Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12(6):542-50.

Dettman G, Kalokerinos A, Dettmann I, Vitamin C. Nature’s Miraculous Healing Missile! Melbourne: Frederick Todd; 1993: 1-422.

Review of the Management of Adverse Effects Associated with Panvax and Fluvax. Available at http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/adverse-event. Accessed on 06 May 2015.

Report an Adverse Event to a Medicine. Available at http://www.tga.gov.au/safety/problem-medicine.htm. Accessed 06 May 2015.

National Health Medical Research Council. The Australian Immunisation Handbook. 9th Edition. Canberra: AGPS; 2008.

Council for International Organizations of Medical Sciences: definition and Application of Terms for Vaccine Pharmacovigilance. Report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance. Geneva: Council for International Organizations of Medical Sciences (CIOMS), World Health Organisation; 2012.

Jacobson RM, Adegbenro A, Pankratz VS, Poland GA. Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. Vaccine. 2001;19(17-19):2428-33.

Centers for Disease Control and Prevention (CDC). Global routine vaccination coverage, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1520-2.

Government of India. Adverse Events Following Immunization: surveillance and Response Operational Guidelines. New Delhi: Ministry of Health and Family Welfare, Government of India; 2010.

World Health Organization. Surveillance of Adverse Events Following Immunization, Field Guide for Managers of Immunization Programs. Geneva: World Health Organization; 1997.